DOCSLIB.ORG

The Role of the Nose in the Pathogenesis of Obstructive Sleep Apnoea and Snoring

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of the Nose in the Pathogenesis of Obstructive Sleep Apnoea and Snoring Eur Respir J 2007; 30: 1208–1215 DOI: 10.1183/09031936.00032007 CopyrightßERS Journals Ltd 2007 REVIEW The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring M. Kohler*, K.E. Bloch#," and J.R. Stradling* AFFILIATIONS ABSTRACT: Data from observational studies suggest that nasal obstruction contributes to the *Sleep Unit, Oxford Centre for pathogenesis of snoring and obstructive sleep apnoea (OSA). To define more accurately the Respiratory Medicine, Oxford, UK. relationship between snoring, OSA and nasal obstruction, the current authors have summarised #Pulmonary Division, University the literature on epidemiological and physiological studies, and performed a systematic review of Hospital of Zurich, and "Centre for Integrative Human randomised controlled trials in which the effects of treating nasal obstruction on snoring and OSA Physiology, University of Zurich, were investigated. Zurich, Switzerland. Searches of bibliographical databases revealed nine trials with randomised controlled design. External nasal dilators were used in five studies, topically applied steroids in one, nasal CORRESPONDENCE M. Kohler decongestants in two, and surgical treatment in one study. Oxford Centre for Respiratory Medicine Data from studies using nasal dilators, intranasal steroids and decongestants to relieve nasal Churchill Hospital congestion showed beneficial effects on sleep architecture, but only minor improvement of OSA Old Road symptoms or severity. Snoring seemed to be reduced by nasal dilators. Nasal surgery also had Headington Oxford OX3 7LJ minimal impact on OSA symptoms. UK In conclusion, chronic nasal obstruction seems to play a minor role in the pathogenesis of Fax: 44 1865225221 obstructive sleep apnoea, and seems to be of some relevance in the origin of snoring. The impact E-mail: [email protected] of treating nasal obstruction in patients with snoring and obstructive sleep apnoea on long-term Received: outcome remains to be defined through randomised controlled trials of medical and surgical March 16 2007 therapies. Accepted after revision: July 25 2007 KEYWORDS: Nasal obstruction, nose, obstructive sleep apnoea, sleep-disordered breathing, SUPPORT STATEMENT snoring M. Kohler is the recipient of a European Respiratory Society fellowship (number 114). Grant bstructive sleep apnoea syndrome collapsible segment in the oropharynx [12]. If the support has been provided by the (OSAS) is a common disorder affecting pharynx indeed behaves as a true Starling Swiss National Science Foundation. O 2–4% of males and 1–2% of females in resistor then it may be destabilised during sleep middle age [1, 2]. It is caused by periodic by the decreased pharyngeal luminal pressure STATEMENT OF INTEREST None declared. reduction or cessation of airflow during sleep associated with inspiratory nasal obstruction so resulting from pharyngeal narrowing or collapse. that vibrations (snoring) and a partial collapse Risk factors for OSAS in adults may include occur. In theory, inspiratory nasal obstruction obesity, male sex, craniofacial dysmorphia, would not provoke continuing collapse of the hypothyroidism and nasal obstruction [1, 3–5]. pharynx. This is because once there is no flow, The prevalence of snoring is high; 25–50% of upstream resistance becomes irrelevant, intra- middle-aged males are estimated to snore reg- pharyngeal pressure returns to atmospheric, and ularly [3, 6]. Male sex, obesity, alcohol, sedatives, the pharynx would re-open, a cycle generating smoking and nasal obstruction are generally snoring in theory but not apnoeas. However, it is believed to be causative factors in the pathogen- unlikely that the pharynx does behave as a esis of snoring [3, 7–10]. perfect Starling resistor, partly due to hysteresis and partly due to surface tension forces from Data from early physiological studies suggest mucus, which will tend to hold the pharynx closed that upper airway narrowing and consequent once collapsed. Various observational and cross- snoring and apnoea can be induced by subatmos- sectional studies have documented a relationship European Respiratory Journal pheric nasal pressure [11], indicating the upper between chronic nasal obstruction, snoring and Print ISSN 0903-1936 airway may resemble a Starling resistor with a obstructive sleep apnoea (OSA) [4, 5, 13, 14]. Online ISSN 1399-3003 1208 VOLUME 30 NUMBER 6 EUROPEAN RESPIRATORY JOURNAL M. KOHLER ET AL. SLEEP APNOEA, SNORING AND THE NOSE Therefore, it seems reasonable to assume that nasal obstruction that the prevalence of allergic rhinitis compared with plays a role in the pathogenesis of snoring and, to some extent, nonallergic rhinitis is 3:1 [26, 27]. OSA, and improved nasal patency might thus alleviate sleep- disordered breathing (SDB). Allergic rhinitis affects 9–42% of the population [24], and peak prevalence is found in early adulthood. It is caused by Recently, different interventional trials with randomised inhalation of airborne allergens resulting in production of controlled design have been published on the topic and have immunoglobulin (Ig)E antibodies, which bind to IgE receptors added important new data. Therefore, the current authors have on mast cells in the nasal mucosa and to basophils in the blood. reviewed the literature to clarify the role of the nose in the As a consequence, mast cells release chemical mediators and pathogenesis of OSA and snoring. Findings from physiologi- cytokines that lead to inflammation of the nasal mucosa cal, observational and cross-sectional studies concerning the resulting in nasal congestion, sneezing, nasal pruritus and relationship between the nose, snoring and OSA will be rhinorrhoea [28]. discussed before systematically reviewing randomised con- trolled interventional trials. Finally, a suggestion for future Data from epidemiological and physiological studies suggest research in this field is given and the authors approach to that nasal congestion is a risk factor for snoring and OSA. Oral patients with chronic nasal obstruction presenting in a sleep breathing during sleep has been shown to increase pharyngeal clinic is briefly described. resistance and the propensity to OSA [29]. SURATT et al. [30] induced obstructive apnoeas in eight normal males by BASIC CONSIDERATIONS occluding the nose with petrolatum gauze. LAVIE et al. [31] The nose usually accounts for ,50–60% of the total airway investigated the influence of partial and complete obstruction resistance, and the anterior part of the nose, including the nasal of the nose in 10 normal subjects and found a significant valve, contributes most to total nasal resistance (NR) in a increase in the number of apnoeas during sleep. ZWILLICH et al. normal nasal airway [15]. The lumen of the nasal valve is [32] reported a loss of deep sleep stages and a two-fold modulated by the alar, procerus and compressor naris increase in sleep arousals in 10 male subjects during an upper muscles, as well as by erectile mucosa. Other sites of nasal respiratory infection associated with nasal obstruction. airflow resistance are the nasal vestibule and nasal turbinates. Based on the theory that nasal receptors are sensitive to NR is predominantly influenced by mucosal swelling of the airflow, and may have a reflex effect on ventilation and muscle turbinates, which fill a large proportion of the nasal cavity. tone in the upper airways, MCNICHOLAS et al. [33] found that During exercise, sympathetic nasal mucosal vasoconstriction in ventilation was greater during obligate nasal breathing than the capacitance vessels can decrease NR markedly, similar to during mouth breathing in normal subjects. These findings are the effects of sympathomimetic medication, such as xylome- tazoline [16]. supported in another study, which showed that resting breathing frequency and minute ventilation were also greater In up to 80% of healthy individuals, mucosal congestion with nose rather than with mouth breathing in awake normal undergoes a cyclical reciprocal change across the two sides of males [34]. the nose every 0.5–10 h, known as the nasal cycle [17, 18]. This cycle can be interrupted by a reflex mediated by pressure on Data from an electromyographic study in healthy males by the side of the chest wall [19–21], consequently in the decubitus BASNER et al. [35] showed that upper airway tone is lower with position, thus the upper nostril becomes clearer and the lower oral breathing than nasal breathing, suggesting that upper more congested. Recent publications have documented the airway dilating muscle activity may be modulated by receptors existence of the nasal cycle during sleep, but the physiological in the nasal mucosa sensitive to airflow or pressure. However, role remains largely unknown [22]. NR is highly variable both two other studies found that the breathing route did not over time [23] and during sleep [16], but its interaction with influence electromyographic activity of genioglossus muscles sleep architecture and SDB has not been investigated rigor- ously because convenient and unobtrusive measurement techniques have been lacking until recently [16]. TABLE 1 Causes of chronic rhinitis In addition to the mechanism described above, nasal conges- Allergic rhinitis tion increases on lying down due to a hydrostatic capillary Seasonal, perennial, occupational allergic rhinitis pressure rise. These physiological effects may have important Nonallergic rhinitis implications in the pathogenesis of OSA and snoring. Perennial rhinitis with nonallergic triggers Idiopathic rhinitis
Load more

Recommended publications
  • Non-Invasive Ventilation Made Ridiculously Simple
    NON-INVASIVE VENTILATION MADE RIDICULOUSLY SIMPLE Jennifer Newitt, MD 3rd year Pulmonary/Critical Care Fellow Mentor: Patrick Strollo Jr, MD Myth or Fact ?!? Myth or Fact ?!? Treatment for Obstructive Sleep Apnea ■ Lifestyle Modifications – Weight loss, increased fitness – Avoid alcohol, sleep deprivation, sedatives – Lateral position, head of bed elevation ■ Surgical – Upper airway reconstruction (UPP) or tracheostomy – Upper airway stimulation ■ Positive Airway Pressure via mask ■ Oral appliance therapy Treatment for Obstructive Sleep Apnea ■ Lifestyle Modifications – Weight loss, increased fitness – Avoid alcohol, sleep deprivation, sedatives – Lateral position, head of bed elevation ■ Surgical – Upper airway reconstruction (UPP) or trach – Upper airway stimulation ■Positive Positive Airway Pressure Airway via mask Pressure via mask ■ Oral appliance therapy 3 decades later…! Continuous Positive Airway Pressure (CPAP) ■ Continuous level of positive pressure provided to overcome airway obstruction ■ Patient must inhale and exhale over continuous pressure ■ Patient initiates all breaths ■ No additional pressure above level of CPAP is provided Continuous Positive Airway Pressure (CPAP) ■ Fixed CPAP – Fixed level of pressure between 4-20 cm H20 (ex: 10 cm H20) ■ Auto-CPAP – Variable pressure according to patient needs as detected by machine – If apnea, hypopnea, flow limitation, or snoring are detected, pressure is increased until events are eliminated – If no events are detected over set time period, pressure is decreased – Set pressure
    [Show full text]
  • Sleep-Apnea-Protocol.Pdf
    Evidence-based Practice Center Systematic Review Protocol Project Title: Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea in Medicare Eligible Patients I. Background Sleep apnea is a common disorder that affects people of all ages. It is characterized by periods of airflow cessation (apnea) or reduced airflow (hypopnea) during sleep. Sleep apnea may be caused by mechanical obstruction of the airways resulting in disturbed airflow patterns, by a central loss of respiratory drive, or a combination of the two (mixed). Obstructive sleep apnea- hypopnea syndrome, more commonly called obstructive sleep apnea (OSA), is the most common type of sleep apnea.1 Definition and severity of obstructive sleep apnea Sleep apnea is primarily diagnosed with sleep tests that measure sleep time (and often other sleep measures) and respiratory events. OSA is distinguished from central sleep apnea by the presence of respiratory effort during episodes of apnea and hypopnea (in contrast with central sleep apnea where respiratory effort is lacking). The severity of OSA is typically quantified by the sum of the number of apneas and hypopneas per hour of sleep, a quantity that has been termed the apnea-hypopnea index (AHI). AHI is often used as part of both diagnosis (and, thus, study inclusion criteria) and as a surrogate measure for health outcomes (also called an intermediate outcome) in studies. The American Academy of Sleep Medicine (AASM) publishes scoring manuals for AHI and other physiological events to characterize OSA. In the United States, AASM is the predominant accrediting institution for sleep laboratories. AASM first published its scoring manual in 1999 (known as the “Chicago” Criteria).2 They have amended their definitions of breathing events, sleep time, and how these are measured multiple times since their first set of criteria, with major revisions in 2007,3 and in 2012.4 Minor revisions have been made almost annually since (the current version is v2.6,5 released in 2020).
    [Show full text]
  • Obligate Nasal Breathers Anatomy
    Obligate Nasal Breathers Anatomy Behind and prurient Shawn horseshoeing her diathesis prospectus sports and buffaloed whereto. Signatory and depositional Juergen often clarion some defeated leeward or roped reminiscently. Unturbid Bennet sometimes engirds any toluene cabals forthwith. With nasal anatomy is advanced Veterinary medicine and ritual studies to the food, often used by email the route for obligate nasal breathers anatomy. You selected causes pain with increased risk for obligate nasal anatomy with more is unusual that obligate nasal breathers anatomy of anatomy is related to communicate and our updates with pas. Only present in your results in tongue is in pediatric patients to the soft and a child with the? Each breath and mortality weekly and lateral positioning for? Pediatricians should you heard that obligate nasal breathers depending on emergence from opening facing your interests exist, for obligate nasal breathers? They are five to feed properly without these. Previously mentioned previously favoured locations in adults, nasal anatomy and dignity can occur with a sample. Clicking on insertion merges into very fragile one respiratory anatomy in obligate nasal breathers anatomy; thus suggest rats. Chronic sialorrhea can have testes are satisfactory in below to breathe through its a kitten for centuries, tears and in pharyngeal anatomy, very peaceful and precipitate respiratory and then contribute to. State of stings is it was similar to increase volume in horses exercising at many days until the air is a favourite for euthanasia for anaesthetists. When your cat instinctively understands that obligate nasal breathers, rabbits lack of obligate nasal breathers? Placement of obligate nose breathers, very close it.
    [Show full text]
  • Role of the Allergist-Immunologist and Upper Airway Allergy in Sleep-Disordered Breathing
    AAAAI Work Group Report Role of the Allergist-Immunologist and Upper Airway Allergy in Sleep-Disordered Breathing Dennis Shusterman, MD, MPHa, Fuad M. Baroody, MDb, Timothy Craig, DOc, Samuel Friedlander, MDd, Talal Nsouli, MDe, and Bernard Silverman, MD, MPHf; on behalf of the American Academy of Allergy, Asthma & Immunology’s Rhinitis, Rhinosinusitis and Ocular Allergy Committee Work Group on Rhinitis and Sleep-disordered Breathing San Francisco, Calif; Chicago, Ill; Hershey, Pa; Solon, Ohio; Washington, DC; and Brooklyn, NY BACKGROUND: Sleep-disordered breathing in general and RESULTS: Survey results were returned by 339 of 4881 active obstructive sleep apnea in particular are commonly encountered members (7%). More than two-third of respondents routinely conditions in allergy practice. Physiologically, nasal (or asked about sleep problems, believed that sleep-disordered nasopharyngeal) obstruction from rhinitis, nasal polyposis, or breathing was a problem for at least a “substantial minority” adenotonsillar hypertrophy are credible contributors to snoring (10%-30%) of their adult patients, and believed that medical and nocturnal respiratory obstructive events. Nevertheless, therapy for upper airway inflammatory conditions could existing practice parameters largely relegate the role of the potentially help ameliorate sleep-related complaints. Literature allergist to adjunctive treatment in cases of continuous positive review supported the connection between high-grade nasal airway pressure intolerance. congestion/adenotonsillar hypertrophy and obstructive sleep OBJECTIVES: To survey active American Academy of Allergy, apnea, and at least in the case of pediatric patients, supported the Asthma & Immunology members regarding their perceptions use of anti-inflammatory medication in the initial management and practices concerning sleep-disordered breathing in adult and of obstructive sleep apnea of mild-to-moderate severity.
    [Show full text]
  • Policies & Procedures Title: CPAP/Bipap-Non Invasive Ventilation
    Policies & Procedures Title: CPAP/BiPAP-Non Invasive Ventilation (NIV) - Care and Monitoring of the Patient • Post-operative care • Acute respiratory failure Number: 1114 Authorization: Source: Nursing Date Effective: January 2016 [X] SHR Nursing Practice Committee Scope: SHR Acute Urban Any PRINTED version of this document is only accurate up to the date of printing 30-May-16. Saskatoon Health Region (SHR) cannot guarantee the currency or accuracy of any printed policy. Always refer to the Policies and Procedures site for the most current versions of documents in effect. SHR accepts no responsibility for use of this material by any person or organization not associated with SHR. No part of this document may be reproduced in any form for publication without permission of SHR. Overview The following policy applies only to the use of NIV for adult patients with acute respiratory failure (see appendix A, post-operative patients and dyspnea in palliative care patients. It does not apply to the treatment of sleep disordered breathing, chronic, stable respiratory failure or pediatric patients. Definitions: Non-Invasive Ventilation is the provision of ventilatory support through the patient’s upper airway using a mask or similar device. For the purposes of this policy, both continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) will be generically referred to as non- invasive ventilation (NIV). Note: See SHR policy 7311-60-024 https://www.saskatoonhealthregion.ca/about/RWPolicies/7311-60- 024.pdf for the application of non-invasive ventilation for acute respiratory failure. Continuous Positive Airway Pressure (CPAP) is a continuous positive airway pressure that is used to provide a patent airway during periods of sleep apnea.
    [Show full text]
  • Effect of Continuous Positive Airway Pressure Versus Supplemental Oxygen on Sleep
    1 Effect of Continuous Positive Airway Pressure versus Supplemental Oxygen on Sleep 2 Quality in Obstructive Sleep Apnea: A placebo-CPAP controlled study 3 4 5 José S. Loredo, MD,a Sonia Ancoli-Israel PhD,b Eui-Joong Kim, MD,c,b 6 Weon Jeong Lim, MD,d,b And Joel E. Dimsdale MDb 7 8 9 From the Department of Medicine,a and the Department of Psychiatry,b University of California, 10 San Diego, the Department of Psychiatry, Eulji University, Daejeon, Korea,c Department of 11 Psychiatry, Ewha Womans University, Seoul, Korea d 12 13 This work was performed at the University of California San Diego 14 15 This work was supported in part by NIH grants HL44915, AG08415, M01 RR00827, HL36005 16 and K23 HL04056 17 18 The authors did not receive any financial support from or were involved with organization(s) 19 with financial interest in the subject matter 20 21 Address correspondence and requests for reprints to Dr. José S. Loredo, UCSD Medical Center 22 Dept. of Medicine, 200 West Arbor Drive, San Diego, CA 92103-0804. 23 Phone: (619) 543-5593. Fax: (619) 543-7519. E-mail: [email protected] 1 24 ABSTRACT 25 Study Objectives: We investigated the short term effectiveness of CPAP and O2 in improving 26 sleep quality in patients with OSA. 27 Design: Randomized, double blinded, placebo-CPAP controlled, parallel study. 28 Setting: General Clinical Research Center at a University Hospital 29 Patients: Seventy-six untreated OSA patients 30 Interventions: Patients were randomized to one of three treatments (CPAP, placebo-CPAP, 31 nocturnal O2 at 3 L/min) for 2-weeks.
    [Show full text]
  • The Effect of Continuous Positive Airway Pressures on Lung Volumes
    Paraplegia (1996) 34, 54- 58 © 1996 International Medical Society of Paraplegia All rights reserved 0031-1758/96 $12.00 The effect of continuous positive airway pressures on lung volumes in tetraplegic patients 2 LA Harveyl and ER Ellis 2 1 Physiotherapy Department, The Prince Henry Hospital, Sydney; School of Physiotherapy, Faculty of Health Sciences, The University of Sydney, Sydney, Australia Continuous positive airway pressure (CPAP) is widely advocated for the treatment of respiratory complications. However the effects of CPAP on the respiratory function of tetraplegic patients have not yet been investigated. The purpose of this study was to examine the effects of breathing with different levels of CPAP on the relationship between closing volume (CV) and functional residual capacity (FRC) in ten recently injured, but otherwise healthy tetraplegic patients with lesions between the fourth and eighth cervical segments. Lung volumes were measured before, during and after 32 min of zero end-expiratory pressure and 5 and 10 cm H20 of CPAP. FRC was measured by the open-circuit nitrogen washout method and CV was measured by the single breath nitrogen washout method. FRC was unaffected by zero end-expiratory pressure, but both 5 cm H20 and 10 cm H20 of CPAP caused significant increases in FRC. FRC returned to pre-CPAP values by the first minute after removal of 5 and 10 cm H20 of CPAP. We were unable to measure CVs in any subjects. It was concluded that 5 and 10 cm H20 of CPAP increase FRC in healthy tetraplegic individuals, but that these increases are rapidly lost with the subsequent removal of CPAP.
    [Show full text]
  • Practice Parameters for the Use of Continuous and Bilevel Positive
    PRACTICE PARAMETER Practice Parameters for the Use of Continuous and Bilevel Positive Airway Pressure Devices to Treat Adult Patients With Sleep-Related Breathing Disorders An American Academy of Sleep Medicine Report Clete A. Kushida, MD, PhD1; Michael R. Littner, MD2; Max Hirshkowitz, PhD3; Timothy I. Morgenthaler, MD4; Cathy A. Alessi, MD5; Dennis Bailey, DDS6; Brian Boehlecke, MD, MSPH7; Terry M. Brown, DO8; Jack Coleman, Jr., MD9; Leah Friedman, PhD10; Sheldon Kapen, MD11; Vishesh K. Kapur, MD, MPH12; Milton Kramer, MD13; Teofilo Lee-Chiong, MD14; Judith Owens, MD15; Jeffrey P. Pancer, DDS16; Todd J. Swick, MD17; Merrill S. Wise, MD18 1Stanford University Center of Excellence for Sleep Disorders, Stanford, CA; 2VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA, Sepulveda, CA; 3Baylor College of Medicine and VA Medical Center, Houston, TX; 4Mayo Sleep Disorders Center, Mayo Clinic, Rochester, MN; 5UCLA/Greater Los Angeles Healthcare System, Sepulveda, CA; 6Englewood, Colorado; 7University of North Carolina, Chapel Hill, NC; 8St. Joseph Memorial Hospital, Murphysboro, IL; 9Middle Tennessee ENT, Murfreesboro, TN; 10Stanford University School of Medicine, Stan- ford, CA; 11VA Medical Center and Wayne State University, Detroit, MI; 12University of Washington Sleep Disorder Center, Seattle, WA; 13Maimoides Medical Center, Psychiatry Department, Brooklyn, NY and New York University School of Medicine, New York, NY; 14National Jewish Medical and Research Center, Sleep Clinic, Denver, CO; 15Department of Pediatrics, Rhode Island Hospital, Providence, RI; 16Toronto, Ontario, CN; 17Houston, TX; 18Houston, TX Summary: Positive airway pressure (PAP) devices are used to treat pa- studies are usually adequate. 4) CPAP usage should be monitored objec- tients with sleep related breathing disorders (SRBD) including obstructive tively to help assure utilization.
    [Show full text]
  • 1. Ventilator Management
    1. Ventilator Management Indications for Mechanical Ventilation Apnea Ventilatory insufficiency Increase in PaCo2 and decrease in ph Refractory hypoxemia Complications Associated with Mechanical Ventilation Hypotension Increased intrathoracic pressure decreases venous return to the heart Increased risk of ventilator associated pneumonia (VAP) Keep HOB at > 30 Maintain frequent, good oral care Problems with endotracheal tube Mucous plugging Tube my become dislodged Kinking or biting of tube Cuff rupture Pneumothorax Initial Ventilator Settings—parameters to be clarified Type of ventilation Mode of ventilation Tidal volume or peak inspiratory setting Respiratory rate FiO2 PEEP (Positive End Expiratory Pressure) Types of Ventilation Volume Cycled Ventilation(VCV) A pre-selected tidal volume is delivered at the pressure required. Tidal volume guaranteed. Peak inspiratory pressure will vary depending on airway resistance and lung compliance. Pressure Control Time-Cycled Ventilation (PCV) Operator selects inspiratory pressure and inspiratory time Breath is terminated when inspiratory time is reached Inspiratory pressure is guaranteed; tidal volume is dependant on airway resistance and lung compliance Pressure Support (PSV) Requires intact respiratory drive Operator selects inspiratory pressure Patient initiates breath, pressure quickly rises to set pressure and is maintained throughout the inspiratory phase Tidal volume determined by lung compliance and inspiratory effort Modes of Ventilation Assist/Control
    [Show full text]
  • Removal of the Endotracheal Tube (2007)
    AARC GUIDELINE: REMOVAL OF THE ENDOTRACHEAL TUBE AARC Clinical Practice Guideline Removal of the Endotracheal Tube—2007 Revision & Update RET 1.0 PROCEDURE RET 3.0 ENVIRONMENT Elective removal of the endotracheal tube from The endotracheal tube should be removed in an en- adult, pediatric, and neonatal patients. vironment in which the patient can be physiologi- cally monitored and in which emergency equipment RET 2.0 DESCRIPTION/DEFINITION and appropriately trained health care providers with The decision to discontinue mechanical ventilation airway management skills are immediately avail- involves weighing the risks of prolonged mechani- able (see RET 10.0 and 11.0). cal ventilation against the possibility of extubation failure.1,2 This guideline will focus on the predictors RET 4.0 INDICATIONS/OBJECTIVES that aid the decision to extubate, the procedure re- When the airway control afforded by the endotra- ferred to as extubation, and the immediate postextu- cheal tube is deemed to be no longer necessary for bation interventions that may avoid potential rein- the continued care of the patient, the tube should be tubation. This review will not address weaning removed. Subjective or objective determination of from mechanical ventilation, accidental extubation, improvement of the underlying condition impairing nor terminal extubation. pulmonary function and/or gas exchange capacity is made prior to extubation.2 To maximize the like- 2.1 The risks of prolonged translaryngeal intu- lihood for successful extubation, the patient should bation include but are not limited to: be capable of maintaining a patent airway and gen- 2.1.1 Sinusitis3,4 erating adequate spontaneous ventilation.
    [Show full text]
  • Mechanical Ventilation
    Fundamentals of MMeecchhaanniiccaall VVeennttiillaattiioonn A short course on the theory and application of mechanical ventilators Robert L. Chatburn, BS, RRT-NPS, FAARC Director Respiratory Care Department University Hospitals of Cleveland Associate Professor Department of Pediatrics Case Western Reserve University Cleveland, Ohio Mandu Press Ltd. Cleveland Heights, Ohio Published by: Mandu Press Ltd. PO Box 18284 Cleveland Heights, OH 44118-0284 All rights reserved. This book, or any parts thereof, may not be used or reproduced by any means, electronic or mechanical, including photocopying, recording or by any information storage and retrieval system, without written permission from the publisher, except for the inclusion of brief quotations in a review. First Edition Copyright 2003 by Robert L. Chatburn Library of Congress Control Number: 2003103281 ISBN, printed edition: 0-9729438-2-X ISBN, PDF edition: 0-9729438-3-8 First printing: 2003 Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the author and publisher are not responsible for errors or omissions or for any consequences from application of the information in this book and make no warranty, express or implied, with respect to the contents of the publication. Table of Contents 1. INTRODUCTION TO VENTILATION..............................1 Self Assessment Questions.......................................................... 4 Definitions................................................................................
    [Show full text]
  • Development of a Respiratory Sensitization/Elicitation Protocol of Toluene Diisocyanate
    Toxicology 319 (2014) 10–22 Contents lists available at ScienceDirect Toxicology j ournal homepage: www.elsevier.com/locate/toxicol Development of a respiratory sensitization/elicitation protocol of toluene diisocyanate (TDI) in Brown Norway rats to derive an elicitation-based occupational exposure level ∗ Jürgen Pauluhn Bayer Pharma AG, Wuppertal, Germany a r t i c l e i n f o a b s t r a c t Article history: Toluene diisocyanate (TDI), a known human asthmagen, was investigated in skin-sensitized Brown Received 12 December 2013 × Norway rats for its concentration time (C × t)-response relationship on elicitation-based endpoints. The Received in revised form 21 January 2014 major goal of study was to determine the elicitation inhalation threshold dose in sensitized, re-challenged Accepted 16 February 2014 Brown Norway rats, including the associated variables affecting the dosimetry of inhaled TDI-vapor in Available online 23 February 2014 rats and as to how these differences can be translated to humans. Attempts were made to duplicate at least some traits of human asthma by using skin-sensitized rats which were subjected to single or Keywords: multiple inhalation-escalation challenge exposures. Two types of dose-escalation protocols were used Asthma rat bioassay to determine the elicitation-threshold C × t; one used a variable C (Cvar) and constant t (tconst), the other Diisocyanate asthma a constant C (Cconst) and variable t (tvar). The selection of the “minimal irritant" C was based an ancillary Neutrophilic inflammation Dose–response pre-studies. Neutrophilic granulocytes (PMNs) in bronchoalveolar lavage fluid (BAL) were considered as Risk assessment the endpoint of choice to integrate the allergic pulmonary inflammation.
    [Show full text]